Holen Sie sich die Stockscreener-App
1.77
3.80%
-0.07
Handel nachbörslich:
1.77
Schlusskurs vom Vortag:
$1.84
Offen:
$1.79
24-Stunden-Volumen:
26,316
Relative Volume:
0.06
Marktkapitalisierung:
$2.61M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1775
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-3.80%
1M Leistung:
+11.32%
6M Leistung:
-65.96%
1J Leistung:
-89.79%
1-Tages-Spanne:
$1.67
$1.8275
1-Wochen-Bereich:
$1.66
$1.915
52-Wochen-Spanne:
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.77 | 2.61M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
HC Wainwright Reiterates “Neutral” Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals Announces 2024 Annual Results - The Manila Times
140% Revenue Surge: 60 Degrees Pharma Expands Drug Access After FDA Approval - Stock Titan
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World
Short Interest in Hilton Small-MidCap Opportunity ETF (NASDAQ:SMCO) Declines By 93.8% - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
IntegriChain Hosts Revenue Analytics Collaborative Summit - PR Newswire
Research Analysts Issue Forecasts for SXTP Q4 Earnings - Defense World
HC Wainwright Reaffirms “Neutral” Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
What is HC Wainwright’s Estimate for SXTP Q1 Earnings? - Defense World
60 Degrees Pharmaceuticals announces 1-for-5 reverse stock split; shares fall - MSN
A company insider recently bought 6,000 shares of 60 Degrees Pharmaceuticals Inc [SXTP]. Should You Buy? - Knox Daily
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - GlobeNewswire
From Malaria to New Markets: How This Pharma CEO Plans to Transform ARAKODA's Future - Stock Titan
60 Degrees Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals enacts reverse stock split - Investing.com India
60 Degrees Pharmaceuticals to Implement 1-for-5 Reverse Stock Split; Shares Down - Marketscreener.com
60 Degrees Pharmaceuticals, Inc. Announces 1-for-5 Reverse Stock Split to Comply with Nasdaq Listing Requirements - Nasdaq
Can This 1-for-5 Reverse Split Save 60 Degrees Pharma's Nasdaq Status? - StockTitan
Magnera to present at JP Morgan's Global Leveraged Finance Conference - The Manila Times
Weiss Ratings Reaffirms “Sell (E+)” Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
60 Degrees Pharmaceuticals files to sell 3.74M shares of common stock for holders - MSN
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF® - The Manila Times
60 Degrees Gets FDA Clearance to Import Antimalarial From Australia to Ensure Supply Continuity - Marketscreener.com
Sixty Degrees Pharmaceuticals to Ensure Continuity of - GlobeNewswire
Malaria Drug Shortage Averted: FDA Green-Lights Australian Import for Critical U.S. Supply - StockTitan
60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Bioceres Crop Solutions Corp (BIOX) Becoming More Attractive for Investors - Knox Daily
Balance Sheet Insights: 60 Degrees Pharmaceuticals Inc (SXTP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Insiders Give Up US$71k As 60 Degrees Pharmaceuticals Stock Drops To US$0.55 - Simply Wall St
60 Degrees Pharmaceuticals Inc [SXTP] Records 200-Day SMA of $1.8142 - Knox Daily
60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.075 Million - Nasdaq
Pharmaceutical Funding Alert: 60 Degrees Secures Fresh Capital Through Strategic Share Offering - StockTitan
Form 424B5 60 DEGREES PHARMACEUTICA - StreetInsider.com
How does 60 Degrees Pharmaceuticals Inc (SXTP) change from a tortoise to a hare? - SETE News
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering - citybiz
60 Degrees Pharmaceuticals Secures $1.1 Mln In Registered Direct Offering - Nasdaq
60 Degrees Pharmaceuticals, Inc. Announces $1.075 Million Registered Direct Offering and Concurrent Private Placement of Common Stock and Warrants - Nasdaq
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
Pharma Stock Alert: SXTP Secures Fresh Capital Through Strategic Share Offering at $0.715 - StockTitan
Weiss Ratings Reiterates Sell (E+) Rating for 60 Degrees Pharmaceuticals (NASDAQ:SXTP) - Defense World
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis - ACCESS Newswire
SXTP stock touches 52-week low at $0.7 amid market challenges - MSN
60 Degrees Pharmaceuticals, Inc. Closes Registered Direct Offering and Concurrent Private Placement Raising Approximately $1.043 Million - Nasdaq
60 Degrees Pharma Announces Closing of $1.043 Million - GlobeNewswire
60 Degrees Pharma Secures Fresh Capital: Inside the $1M Financing Deal That's Turning Heads - StockTitan
60 Degrees Pharmaceuticals announces stock and warrant sale - MSN
US Stocks Mixed; General Dynamics Earnings Top Views - Benzinga
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
| XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):